(Total Views: 34)
 Posted On: 10/21/2025 12:49:58 PM 
  
		  		    Post#  of 103183		    
			
		      
  
	News Alert:  $BCTX announces a key collaboration with Memorial Sloan Kettering’s Therapeutics to advance its next-gen immunotherapy Bria-OTS+™, starting with breast cancer. A major step forward powered by MSK’s clinical expertise. 
 
https://globenewswire.com/news-release/2025/1...ancer.html
 	
 
https://globenewswire.com/news-release/2025/1...ancer.html
 (0)
(0) (0)
(0) 
      			 
 
  
    
      
    












